Consolidated Revenue Growth
Total revenue of nearly $1.1 billion in Q1, up almost 8% year-over-year on a reported basis and up just over 5% on a core basis (note: core growth benefited from ~150 basis points of selling days tailwind).
Strong Profitability and Margin Expansion
Adjusted EBITDA of $314 million, up ~13% year-over-year; adjusted EBITDA margin expanded ~140 basis points to just over 29%.
Material EPS Growth
Adjusted EPS of $0.70 in Q1, up over 25% year-over-year — the third consecutive quarter of double-digit adjusted EPS growth.
Free Cash Flow and Conversion
$194 million of free cash flow in Q1 with trailing twelve-month free cash flow conversion north of 100%.
Share Repurchase Program
Deployed approximately $500 million to share repurchases in Q1; ~$1.8 billion deployed since the spin (about 35 million shares), reducing diluted share count by just over 10% since July 2025.
Segment Performance — Intelligent Operating Solutions (IOS)
IOS revenue grew ~8% reported and ~5% core; segment adjusted EBITDA of $255 million, up ~8% year-over-year; adjusted gross margin ~65% (despite tariff headwinds) and adjusted EBITDA margin just over 34%.
Segment Performance — Advanced Healthcare Solutions (AHS)
AHS total revenue of $326 million, up ~8% year-over-year (~6% core); adjusted EBITDA of $84 million, up ~18% year-over-year; adjusted EBITDA margin expanded ~200 basis points to just under 26%.
Recurring Revenue and Software Strength
Recurring revenue grew faster than consolidated revenue in both segments; notable double-digit services growth at Fluke and strong software growth across the portfolio (AI-enabled product launches such as Provation Mirror Documentation Assist).
Product and Commercial Momentum
Successful new product launches and commercial traction — CertiFiber Max driving pull-through at Fluke, strong order growth (orders outpacing revenue at Fluke with book-to-bill >1), and positive early results from made-in-region strategies in India and China.
Capital Allocation and M&A Readiness
Disciplined capital allocation with clear priorities: invest in organic growth, pursue bolt-on M&A, continue share repurchases, and maintain a modest growing dividend; two small bolt-on integrations tracking to plan and corporate development team strengthened.
Reaffirmed Full-Year Guidance
Reaffirmed full-year adjusted EPS guidance of $2.90–$3.00 and indicated results are trending toward the upper half of the range; modeling full-year reported revenue of ~ $4.3 billion and core growth of 2%–3%.